Paper42012273
Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration.
Shi J and 7 others. Invest Ophthalmol Vis Sci, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration. Papers, record 42012273. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42012273
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Recombinant Fusion Proteins | Major topic |
| Genetic Therapy | Major topic |
| Receptors, Vascular Endothelial Growth Factor | Major topic |
| Dependovirus | Major topic |
| Choroidal Neovascularization | Major topic |
| Macular Degeneration | Major topic |
| Wet Macular Degeneration | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Gene Therapy Agents | |
| Disease Models, Animal | |
| Vascular Endothelial Growth Factor A | |
| Female | |
| Genetic Vectors | |
| Male | |
| Treatment Outcome | |
| Visual Acuity | |
| Macaca fascicularis |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31146917 | Gene delivery to cone photoreceptors by subretinal injection of rAAV2/6 in the mouse retina. | Biochem Biophys Res Commun | 2019 | https://conductscience.org/library/papers/31146917 | PubMed |
| 2 | 30710128 | Adeno-associated virus vector as a platform for gene therapy delivery. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30710128 | PubMed |
| 3 | 21825187 | Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates. | Arch Ophthalmol | 2011 | https://conductscience.org/library/papers/21825187 | PubMed |
| 4 | 16644289 | Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection. | Mol Ther | 2006 | https://conductscience.org/library/papers/16644289 | PubMed |
| 5 | 22523653 | Anti-VEGF Treatment Strategies for Wet AMD. | J Ophthalmol | 2012 | https://conductscience.org/library/papers/22523653 | PubMed |
| 6 | 39908131 | Retinal and Choriocapillaris Thickness Changes in Spontaneously Diabetic Macaques. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/39908131 | PubMed |
| 7 | 25360686 | Standardized full-field electroretinography in the Green Monkey (Chlorocebus sabaeus). | PLoS One | 2014 | https://conductscience.org/library/papers/25360686 | PubMed |
| 8 | 33767261 | High frequency SD-OCT follow-up leading to up to biweekly intravitreal ranibizumab treatment in neovascular age-related macular degeneration. | Sci Rep | 2021 | https://conductscience.org/library/papers/33767261 | PubMed |
| 9 | 29359172 | Nonclinical Safety Evaluation of scAAV8-RLBP1 for Treatment of RLBP1 Retinitis Pigmentosa. | Mol Ther Methods Clin Dev | 2018 | https://conductscience.org/library/papers/29359172 | PubMed |
| 10 | 24144450 | Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration. | Ophthalmology | 2014 | https://conductscience.org/library/papers/24144450 | PubMed |
| 11 | 26603570 | Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal Diseases. | Hum Gene Ther | 2016 | https://conductscience.org/library/papers/26603570 | PubMed |
| 12 | 24136346 | Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. | Nat Protoc | 2013 | https://conductscience.org/library/papers/24136346 | PubMed |
| 13 | 2362376 | Aqueous protein concentration in rhegmatogenous retinal detachment. | Jpn J Ophthalmol | 1990 | https://conductscience.org/library/papers/2362376 | PubMed |
| 14 | 35141350 | Delivery of nVEGFi using AAV8 for the treatment of neovascular age-related macular degeneration. | Mol Ther Methods Clin Dev | 2022 | https://conductscience.org/library/papers/35141350 | PubMed |
| 15 | 38540673 | Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization. | Biomolecules | 2024 | https://conductscience.org/library/papers/38540673 | PubMed |
| 16 | 32185075 | Silicone Oil Emulsification after Vitrectomy for Rhegmatogenous Retinal Detachment. | J Ophthalmol | 2020 | https://conductscience.org/library/papers/32185075 | PubMed |
| 17 | 21119620 | Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration. | Mol Ther | 2011 | https://conductscience.org/library/papers/21119620 | PubMed |
| 18 | 27111455 | The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography. | Lasers Surg Med | 2016 | https://conductscience.org/library/papers/27111455 | PubMed |
| 19 | 30132368 | Dosage Thresholds and Influence of Transgene Cassette in Adeno-Associated Virus-Related Toxicity. | Hum Gene Ther | 2018 | https://conductscience.org/library/papers/30132368 | PubMed |
| 20 | 38710714 | An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species. | Nat Commun | 2024 | https://conductscience.org/library/papers/38710714 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42012273
GET https://conductscience.org/api/papers/v1/42012273/references?page=2